Last Price
123.01
Today's Change
-2.373 (1.89%)
Day's Change
123.00 - 123.03
Trading Volume
100
Overview
Market Cap
18 Billion
Shares Outstanding
145 Million
Avg Volume
3,880
Avg Price (50 Days)
128.85
Avg Price (200 Days)
144.96
PE Ratio
0.00
EPS
0.00
Earnings Announcement
31-Jul-2025
Previous Close
125.38
Open
123.03
Day's Range
123.0 - 123.03
Year Range
123.0 - 123.03
Trading Volume
101
Price Change Highlight
1 Day Change
-1.89%
5 Day Change
-4.27%
1 Month Change
-3.37%
3 Month Change
3.39%
6 Month Change
-13.63%
Ytd Change
-19.06%
1 Year Change
-45.35%
3 Year Change
-40.47%
5 Year Change
-64.04%
10 Year Change
-64.04%
Max Change
-64.04%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Description:
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,800 full-time employees. The firm focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The firm markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). The company also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The firm's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Oxford Innotech Berhad, a precision engineering and automation solutions provider, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1208/Thumbnail_.png)
![[New IPO] Enproserve Group Berhad, a plant maintenance specialist in the O&G sector, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1198/Thumbnail__(10).png)
![[New IPO] Icents Group Holdings Berhad, a specialised construction company focused on cleanroom EPCC services for industries, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1192/Thumbnail__(9).png)
Apps
Top Articles
1
Stumbling and Mumbling
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
